Search results
Johnson & Johnson (NYSE:JNJ) Stake Raised by Vanguard Group Inc.
ETF DAILY NEWS· 6 days agoVanguard Group Inc. raised its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 0.0% during the 4th quarter, according to the company in its most recent 13F filing with the ...
239 Shares in AbbVie Inc. (NYSE:ABBV) Bought by Ables Iannone Moore & Associates Inc.
ETF DAILY NEWS· 6 days agoAbles Iannone Moore & Associates Inc. bought a new stake in AbbVie Inc. (NYSE:ABBV – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities ...
Johnson & Johnson (NYSE:JNJ) Trading Up 0.3%
ETF DAILY NEWS· 5 days agoJohnson & Johnson (NYSE:JNJ – Get Free Report) traded up 0.3% during mid-day trading on Monday . Morgan Stanley dropped their target price on Johnson & Johnson from $168.00 to $167.00 and set ...
Jude Bellingham fans discuss hyperpigmentation over footballer's appearance
Yahoo Life UK· 5 days agoRead more about skin conditions: How a healthy gut microbiome can give you better winter skin (Yahoo...
Free clinic helps educate neighbors on skin health in Southeast DC
WUSA 9 Washington, D.C.· 6 days agoOrganizers say many communities in Wards 7 and 8 are underserved when it comes to dermatology care,...
M&R Capital Management Inc. Has $2.84 Million Holdings in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 5 days agoM&R Capital Management Inc. reduced its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 0.6% during the 1st quarter, according to the company in its most recent filing with the Securities ...
The Best LED Face Masks To Improve Wrinkles And Acne, According To Dermatologists
Women's Health via AOL· 4 days agoThe best FDA-approved LED light therapy face masks, per dermatologists and editors, have benefits...
Top 5 Small-Cap Biotechnology Stocks for a Stable Portfolio
Zacks via Yahoo Finance· 3 days agoARQT is focused on developing and commercializing treatments for unmet needs in immune-mediated...
Hollings Renton Sells 1,950 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) Stock
ETF DAILY NEWS· 5 days agoAnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) Director Hollings Renton sold 1,950 shares of the business’s stock in a transaction dated Tuesday, June 18th. The stock was sold at an average ...
TREMFYA® (guselkumab) studies underscore its potential to be the only IL-23 inhibitor to offer both...
Morningstar· 4 days agoJohnson & Johnson (NYSE: JNJ) today announced positive topline results from the pivotal Phase 3 GRAVITI investigational study of TREMFYA® (guselkumab) subcutaneous (SC) induction therapy in ...